Efficacy and Safety of Nafamostat Mesilate Injection in Patients Receiving Continuous Renal Replacement Therapy: A Meta-Analysis
Journal of Visualized Experiments · 30.10.2026 · (236)
DOI: 10.3791/72188 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Visualized Experiments, online erschienen am 30.10.2026. Verfasst von Yanting Tu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit (ICU), The Second Hospital of Jiaxing. Hauptthemen laut MEDLINE: Guanidines, Continuous Renal Replacement Therapy, Anticoagulants.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Intensive Care Unit (ICU), The Second Hospital of Jiaxing.
- Post-Anesthesia Care Unit (PACU), The Second Hospital of Jiaxing.
- Intensive Care Unit (ICU), The Second Hospital of Jiaxing; 15990344658@163.com.
Zitieren
APA
Tu, Y., Hu, Y., Lv, Q., Zhu, Q., Yu, Y., & Yao, B. (2026). Efficacy and Safety of Nafamostat Mesilate Injection in Patients Receiving Continuous Renal Replacement Therapy: A Meta-Analysis. Journal of Visualized Experiments. https://doi.org/10.3791/72188
Vancouver
Tu Y, Hu Y, Lv Q, Zhu Q, Yu Y, Yao B. Efficacy and Safety of Nafamostat Mesilate Injection in Patients Receiving Continuous Renal Replacement Therapy: A Meta-Analysis. Journal of Visualized Experiments. 2026. doi:10.3791/72188
BibTeX
@article{Tu2026,
author = {Tu, Yanting and Hu, Yuanmin and Lv, Qun and Zhu, Qinyan and Yu, Yanfei and Yao, Bingjie},
title = {Efficacy and Safety of Nafamostat Mesilate Injection in Patients Receiving Continuous Renal Replacement Therapy: A Meta-Analysis},
journal = {Journal of Visualized Experiments},
year = {2026},
number = {236},
doi = {10.3791/72188}
}
EUVIMED